Orexin-A is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Orexin-A is being researched for sleep applications. Activates both OX1R and OX2R G-protein coupled receptors, increasing intracellular calcium through phospholipase C signaling. Broadly activates arousal neural networks including dopaminergic, noradren. Common dosages for this use range from not established for human peptide administration single dose in research protocols.
Can Orexin-A Help With Sleep?
Orexin-A (Hypocretin-1) is being researched for sleep applications based on its mechanism as a Neuropeptide hormone.
Activates both OX1R and OX2R G-protein coupled receptors, increasing intracellular calcium through phospholipase C signaling. Broadly activates arousal neural networks including dopaminergic, noradrenergic, histaminergic, and cholinergic systems to promote wakefulness and prevent cataplexy.
What Does the Research Show for Orexin-A and Sleep?
Most research focuses on orexin receptor agonist drugs (TAK-861) rather than direct peptide administration. Animal models demonstrate robust dose-dependent wakefulness effects. Direct human peptide trials remain extremely limited.
The relevance to sleep specifically comes from Orexin-A's effects on increased wakefulness and arousal, cognitive function in narcolepsy, pain modulation.
What Protocol Is Used for Sleep?
For sleep applications, the standard Orexin-A protocol is not established for human peptide administration administered single dose in research protocols via intranasal (experimental human), intracerebroventricular (animal studies) for single dose protocols; no established multi-week cycles.
Some researchers adjust dosing based on the specific sleep application — see our Orexin-A dosage guide for full protocol details.
Can Stacking Improve Sleep Results?
Could complement circadian-regulating peptides like DSIP (sleep) for full sleep-wake cycle optimization.
What Side Effects Apply to Sleep Use?
Limited human safety data. Potential increased heart rate and blood pressure. Poor blood-brain-barrier penetration limits peripheral dosing.
Side effects are generally consistent regardless of the specific application. See our Orexin-A side effects guide for details.
Calculate Your Orexin-A Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Orexin-A.
Open Calculator →Bottom Line: Orexin-A for Sleep
Orexin-A shows preliminary research potential for sleep. Standard protocols (not established for human peptide administration, single dose in research protocols, single dose protocols; no established multi-week cycles) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
Orexin-A : Benefits, Dosage, Side Effects & Research
Related Reading
- Orexin-A Dosage Guide
- Orexin-A Benefits
- Orexin-A Side Effects
- Orexin-A Stacking Guide
- Orexin-A Cycle Guide
- Orexin-A Research
Research-Grade Sourcing
If you're going to research Orexin-A, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Orexin-A?
Orexin-A (Hypocretin-1) is a Neuropeptide hormone. Naturally occurring peptide synthesized in the hypothalamus, regulating sleep-wake cycles and arousal. It is researched for increased wakefulness and arousal, cognitive function in narcolepsy, pain modulation.
What is the recommended Orexin-A dosage?
Common dosages: not established for human peptide administration administered single dose in research protocols via intranasal (experimental human), intracerebroventricular (animal studies). Cycle length: single dose protocols; no established multi-week cycles. Half-life: rapidly degraded peripherally; central CSF half-life estimated 10-30 minutes. Use our peptide calculator for exact reconstitution math.
What are the side effects of Orexin-A?
Limited human safety data. Potential increased heart rate and blood pressure. Poor blood-brain-barrier penetration limits peripheral dosing.
Is Orexin-A safe?
Orexin-A has shown a preliminary safety profile in research. Not FDA-approved. Research use only. Development focus has shifted to small molecule receptor agonists. All research should follow appropriate safety protocols.